Lv31
260 积分 2024-01-04 加入
Tetramethylpyrazine: A review on its mechanisms and functions
6小时前
已完结
Lycorine and organ protection: Review of its potential effects and molecular mechanisms
6小时前
已完结
Evodiamine: A review of its pharmacology, toxicity, pharmacokinetics and preparation researches
7小时前
已完结
LBA17 ASCENT: A randomized phase III study of sacituzumab govitecan (SG) vs treatment of physician’s choice (TPC) in patients (pts) with previously treated metastatic triple-negative breast cancer (mTNBC)
2天前
已完结
Sacituzumab govitecan in previously treated hormone receptor-positive/HER2-negative metastatic breast cancer: final results from a phase I/II, single-arm, basket trial
2天前
已完结
Sacituzumab Govitecan-hziy in Refractory Metastatic Triple-Negative Breast Cancer
2天前
已完结
Sacituzumab govitecan (IMMU‐132), an anti‐Trop‐2‐SN‐38 antibody‐drug conjugate for the treatment of diverse epithelial cancers: Safety and pharmacokinetics
2天前
已完结
An ADC for Triple-Negative Breast Cancer
2天前
已关闭
Current Trends and Challenges of Microbiome Research in Prostate Cancer
3天前
已完结
Unveiling the Hidden Links: Periodontal Disease, Fusobacterium Nucleatum, and Cancers
3天前
已完结
皖公网安备34019202002308
